TP53 and neoplasm: In addition, CRISPR/Cas9 technology can also be used to repair or knock out oncogenes, and activate or inhibit oncogenes, such as repairing mutations in the tumor suppressor gene TP53, which can restore its normal function and thus inhibit the growth of tumor cells.